Aurora Cannabis (ACB)
(Delayed Data from NSDQ)
$6.24 USD
+0.49 (8.43%)
Updated Jul 22, 2024 03:59 PM ET
After-Market: $6.24 +0.01 (0.08%) 4:40 PM ET
4-Sell of 5 4
C Value B Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Aurora Cannabis Inc. [ACB]
Reports for Purchase
Showing records 1 - 20 ( 39 total )
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: Price Deflation a Needed Market Dynamic to Convert Illicit Mkt
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: Toronto Securities Exchange an Open Pathway for MSO Lisitngs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: California at Inflection on Easing Regulations & Improved Access
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: Early Readthrough Into 1Q22 Confirms Industry Headwinds
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: Israel - Pioneering Cannabis into a Large Market Opportunity
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis SPACs Underperformed in 2021, Reset
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: MJBiz Takeaway Points Toward M&A in a Status Quo Environment
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: Federal Legislation Should Start Heating Up
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: CAOA Feedback, Fall Potential Legislation Passage In Budget Bill
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Weekly ReHash: Ranking 2Q Earnings Reports, Well Capitalized MSOs
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Aurora Cannabis Inc.
Industry: Medical - Products
A Day of Progress for Cannabis Legislative Reform
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Aurora Cannabis Inc.
Industry: Medical - Products
Expectations of Schumer''s Legalization Plan
Provider: Roth Capital Partners, Inc.
Analyst: Research Department